High-Risk HLA-DQ Mismatches Are Associated With Adverse Outcomes After Lung Transplantation
Transplant International · 2024
DOI: 10.3389/ti.2024.13010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplant International, 2024. Verfasst von Lisa Kleid und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Transfusion Medicine, Cell Therapeutics and Haemostaseology, University Hospital, LMU Munich, Munich, Germany. Hauptthemen laut MEDLINE: Lung Transplantation, HLA-DQ Antigens, Graft Rejection. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Human leukocyte antigen (HLA) mismatches (MM) between donor and recipient lead to eplet MM (epMM) in lung transplantation (LTX), which can induce the development of de-novo donor-specific HLA-antibodies (dnDSA), particularly HLA-DQ-dnDSA. Aim of our study was to identify risk factors for HLA-DQ-dnDSA development. We included all patients undergoing LTX between 2012 and 2020. All recipients/donors were typed for HLA 11-loci. Development of dnDSA was monitored 1-year post-LTX. EpMM were calculated using HLAMatchmaker. Differences in proportions and means were compared using Chi2-test and Students’ t-test. We used Kaplan-Meier curves with LogRank test and multivariate Cox regression to compare acute cellular rejection (ACR), chronic lung allograft dysfunction (CLAD) and survival. Out of 183 patients, 22.9% patients developed HLA-DQ-dnDSA. HLA-DQ-homozygous patients were more likely to develop HLA-DQ-dnDSA than HLA-DQ-heterozygous patients ( p = 0.03). Patients homozygous for HLA-DQ1 appeared to have a higher risk of developing HLA-DQ-dnDSA if they received a donor with HLA-DQB1*03:01. Several DQ-eplets were significantly associated with HLA-DQ-dnDSA development. In the multivariate analysis HLA-DQ-dnDSA was significantly associated with ACR ( p = 0.03) and CLAD ( p = 0.01). HLA-DQ-homozygosity, several high-risk DQ combinations and high-risk epMM result in a higher risk for HLA-DQ-dnDSA development which negatively impact clinical outcomes. Implementation in clinical practice could improve immunological compatibility and graft outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Transfusion Medicine, Cell Therapeutics and Haemostaseology, University Hospital, LMU Munich, Munich, Germany.
- Division of Thoracic Surgery, University Hospital, LMU Munich, Munich, Germany.
- Comprehensive Pneumology Center (CPC), Helmholtz Munich, Member of the German Center of Lung Research (DZL), LMU Munich, Munich, Germany.
- Department of Medicine V, LMU Munich University Hospital, Munich, Germany.
- Department of Cardiac Surgery, University Hospital, LMU Munich, Munich, Germany.
- Division of Pulmonology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
Zitieren
APA
Kleid, L., Walter, J., Moehnle, P., Wichmann, C., Kovács, J., Humpe, A., Schneider, C., Michel, S., Kneidinger, N., Irlbeck, M., Fertmann, J., Dick, A., & Kauke, T. (2024). High-Risk HLA-DQ Mismatches Are Associated With Adverse Outcomes After Lung Transplantation. Transplant International. https://doi.org/10.3389/ti.2024.13010
Vancouver
Kleid L, Walter J, Moehnle P, Wichmann C, Kovács J, Humpe A, et al. High-Risk HLA-DQ Mismatches Are Associated With Adverse Outcomes After Lung Transplantation. Transplant International. 2024. doi:10.3389/ti.2024.13010
BibTeX
@article{Kleid2024,
author = {Kleid, Lisa and Walter, Julia and Moehnle, Patrick and Wichmann, Christian and Kovács, Julia and Humpe, Andreas and Schneider, Christian and Michel, Sebastian and Kneidinger, Nikolaus and Irlbeck, Michael and Fertmann, Jan and Dick, Andrea and Kauke, Teresa},
title = {High-Risk HLA-DQ Mismatches Are Associated With Adverse Outcomes After Lung Transplantation},
journal = {Transplant International},
year = {2024},
doi = {10.3389/ti.2024.13010}
}
EUVIMED